Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

325
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
325
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

309
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
309
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

410
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
410
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

299
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unplanned transfer to acute care during inpatient geriatric rehabilitation: incidence, risk factors, and associated short-term outcomes.

BMC geriatrics·2024
Same author

A contribution to the French validation of the clinical anxiety scale amongst health care workers in Switzerland.

BMC psychology·2024
Same author

Qualitative Evaluation of a Pilot Physician Training Program in Long-Term Care Facilities in Switzerland.

Journal of the American Medical Directors Association·2024
Same author

Older people's experience of the partial lockdown during the COVID-19 pandemic in Switzerland: a cross-sectional study.

BMJ open·2023
Same author

Trends in the disability-free life expectancy in Switzerland over a 10-year period: an analysis of survey-based data.

Swiss medical weekly·2023
Same author

Revue medicale suisse·2022
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.8K

[Anticoagulation in old fallers : a common challenge].

Philippe Chassagne1, Marc Humbert1, Sylvain Nguyen1

  • 1Service de gériatrie et réadaptation gériatrique, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|July 12, 2017
PubMed
Summary
This summary is machine-generated.

Long-term anticoagulation effectively reduces stroke risk in atrial fibrillation patients, even in older adults prone to falls and bleeding. The benefits of preventing stroke and its severe consequences outweigh the associated bleeding risks.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Related Experiment Videos

Last Updated: Feb 26, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
05:26

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

1.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.6K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Atrial fibrillation necessitates long-term anticoagulation to prevent thromboembolic events like stroke.
  • Older adults (≥65 years) are at higher risk for falls and subsequent hemorrhagic adverse events.
  • Balancing anticoagulation benefits against bleeding risks is crucial in elderly populations.

Purpose of the Study:

  • To evaluate the net benefit of anticoagulation in older adults with atrial fibrillation, considering stroke risk reduction versus bleeding risk.
  • To determine if the advantages of preventing stroke-related morbidity and mortality outweigh the potential harms of anticoagulation in this demographic.

Main Methods:

  • Review of existing literature and clinical guidelines on anticoagulation in atrial fibrillation.
  • Analysis of stroke incidence, functional dependency, cognitive decline, quality of life, and mortality data.
  • Assessment of hemorrhagic adverse event rates, including those associated with falls.

Main Results:

  • Anticoagulation significantly reduces the incidence of stroke and its associated severe consequences.
  • Despite an increased risk of falls and bleeding in older adults, the protective effect against stroke remains substantial.
  • The overall benefit of anticoagulation in mitigating stroke-related outcomes surpasses the risks of bleeding events.

Conclusions:

  • Long-term anticoagulation is recommended for older adults with atrial fibrillation due to superior benefits in stroke risk reduction.
  • Clinical decisions should weigh the significant advantages of preventing stroke against the manageable risks of anticoagulation-related bleeding.
  • Anticoagulant therapy remains a cornerstone in managing atrial fibrillation for improved long-term health outcomes in the elderly.